KLK3 and posterior cortical atrophy: We have demonstrated an even greater improvement of assay specificity as a result of knowing the concentration of MIC-1 in addition to PSA, and (2) indicating a possible “PCa hot spot” (high risk) on the MIC-1/PSA plot (Fig 4).